New Clinical Trials Under Way for C. Diff Prevention Drug
Clostridium difficile, commonly referred to as C. diff, is a bacterium that makes more than half a million people sick each year. In November of 2014, the Food and Drug Administration approved the next stage of drug development for a product called SYN-004, a treatment “designed to be the first and only prophylactic therapy for [...]